Pancreatitis is a complex, progressively destructive inflammatory disorder. Alcohol was long thought to be the primary causative agent, but genetic contributions have been of interest since the discovery that rare PRSS1, CFTR and SPINK1 variants were associated with pancreatitis risk. We now report two associations at genome-wide significance identified and replicated at PRSS1-PRSS2 (P < 1 × 10 −12 ) and X-linked CLDN2 (P < 1 × 10 −21 ) through a two-stage genome-wide study (stage 1: 676 cases and 4,507 controls; stage 2: 910 cases and 4,170 controls). The PRSS1 variant likely affects disease susceptibility by altering expression of the primary trypsinogen gene. The CLDN2 risk allele is associated with atypical localization of claudin-2 in pancreatic acinar cells. The homozygous (or hemizygous in males) CLDN2 genotype confers the greatest risk, and its alleles interact with alcohol consumption to amplify risk. These results could partially explain the high frequency of alcohol-related pancreatitis in men (male hemizygote frequency is 0.26, whereas female homozygote frequency is 0.07).
The exocrine pancreas is a simple digestive gland of only two primary cell types, each with a single function ( Supplementary Fig. 1 and Supplementary Note). Recurrent acute pancreatic inflammation can but does not always progress to irreversible damage of the gland, including fibrosis, atrophy, pain and exocrine and endocrine insufficiency [1] [2] [3] , known as chronic pancreatitis. Different genetic and environmental factors produce the same clinical phenotype 4 .
We collected biological samples and phenotypic data from 1,000 individuals with recurrent acute pancreatitis and chronic pancreatitis as well as controls in the North American Pancreatitis Study 2 (NAPS2) 5 . The primary environmental risk factor identified was heavy alcohol drinking when symptoms of pancreatitis began, defined on the basis of the assessment of the study physician, termed here alcohol-related pancreatitis.
To further define genetic risk, we conducted a two-stage (discovery and replication) genome-wide association study (GWAS). The final data set for the stage 1 cohort included 676 chronic pancreatitis cases and 4,507 controls of European ancestry ( Supplementary Figs. 2  and 3 ) genotyped at 625,739 SNPs ( Table 1 and Supplementary  Table 1 ). Associations at genome-wide significance (P < 5 × 10 −8 ) were identified at two loci. The most highly associated SNP fell at Xq23.3, termed the CLDN2 locus, and the other was located at 7q34, termed the PRSS1-PRSS2 locus (Fig. 1, Table 2 , Supplementary  Figs. 4 and 5 and Supplementary Table 2 ). CLDN2 encodes the claudin-2 protein, PRSS1 encodes cationic trypsinogen, and PRSS2 encodes anionic trypsinogen.
The stage 2 cohort included 910 cases (331 chronic pancreatitis and 579 recurrent acute pancreatitis; Table 1 and Supplementary Table 1) , also genotyped at 625,739 SNPs, and 4,170 controls, most of whom were genotyped previously on the Illumina HumanOmni1_Quad_V1-0_B chip. All subjects were of European ancestry, as determined by genetic analyses. Recurrent acute pancreatitis and chronic pancreatitis were modeled as having common susceptibilities, with chronic pancreatitis occurring over time in the presence of additional disease-modifying factors 6 . It is possible that this assumption reduces power relative to that of a study comprising solely chronic pancreatitis or recurrent acute pancreatitis cases. Our primary focus in stage 2 was on Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis l e t t e r s the PRSS1-PRSS2 and CLDN2 loci, although we also conducted a joint analysis 7 of data from stages 1 and 2 to uncover any new risk loci. After controlling for ancestry, these data showed significant effects for the CLDN2 and PRSS1-PRSS2 loci ( Fig. 1, Supplementary  Figs. 6 and 7 and Supplementary Tables 2 and 3 ). The quality of the SNP genotypes supported the associations (Supplementary Fig. 8 ).
The frequencies of the putative risk alleles at these two loci were 0.57 for the C allele at rs10273639 (PRSS1-PRSS2 locus), with the minor T allele reducing risk, and 0.26 for the T allele at rs12688220 (CLDN2 locus). No other locus showed association after accounting for SNP genotype quality (Supplementary Figs. 6-8) .
PRSS1 gain-of-function mutations, such as the one encoding a p.Arg122His alteration, increase risk for recurrent acute pancreatitis and chronic pancreatitis 8 , as does increased copy number 9,10 , whereas rare loss-of-function mutations in PRSS2 are protective 11 . rs10273639 is in the 5′ promoter region of PRSS1. Because it is the only highly associated SNP in the locus, we validated its genotypes by independent TaqMan genotyping and also genotyped two SNPs in linkage disequilibrium with it ( Supplementary Table 4 ) 12,13 . We screened PRSS1 for rare variants in 1,138 subjects, 418 with chronic pancreatitis, 350 with recurrent acute pancreatitis and 379 controls. Three known diseaseassociated variants (encoding p.Ala16Val, p.Asn29Ile and p.Arg122His alterations) were identified in 23 subjects ( Supplementary Table 4 ).
These gain-of-function variants occurred almost exclusively in cases (22 out of 23), and 2 of them (encoding p.Ala16Val and p.Arg122His alterations) are likely included on the C or risk haplotype of this locus ( Supplementary Table 4 ). Nonetheless, with only 19 cases harboring alleles encoding p.Ala16Val and p.Arg122His alterations, these rare alleles cannot account for the association observed at this locus.
We genotyped 69 control pancreas tissue samples from 3 sources at rs10273639 and used cDNA to quantify expression of PRSS1 and control genes ( Supplementary Table 5 ). In all three sets of quantitative PCR data, the slope relating the count of the C allele genotype to PRSS1 expression was positive. Taken together, the samples provided evidence that alleles at rs10273639 affect expression of PRSS1 (P = 0.01): expression levels were highest in subjects homozygous for the C allele at rs10273639, intermediate in heterozygotes and lowest in subjects homozygous for the T allele. On the basis of this evidence, we posit that reduced trypsinogen expression protects the pancreas from injury, as has been observed in mouse genetic models 14 .
CLDN2 is considered the primary candidate gene within the X-linked locus. Claudin-2 is an attractive candidate because it serves as a highly regulated tight junction protein, forming low-resistance, cation-selective ion and water channels between endothelial cells 15, 16 , and is normally expressed at low levels in the tight junction between cells of the pancreatic ducts and in pancreatic islets 17, 18 . The CLDN2 promoter includes a nuclear factor (NF)-κB-binding site 19 , and CLDN2 expression is enhanced in other cells under conditions associated with injury or stress [20] [21] [22] . Claudin-2 can also be expressed by acinar cells when stressed, as reported in porcine models of acute pancreatitis 23 . Other genes within the CLDN2 locus include MORC4, RIPPLY1 and TBC1D8B. MORC4 is expressed at low levels in most tissues, including the pancreas, with higher levels detected in the placenta and testes 24 . The MORC4 protein contains a CW four-cysteine zinc-finger motif, nuclear localization signal and nuclear matrix-binding domain, suggesting that it may be a transcription factor 24 , but its expression does not seem to correlate with pancreatitis ( Supplementary Fig. 9 ). RIPPLY1 and TBC1D8B are not known to be expressed in the pancreas.
To our knowledge, genetic variation in CLDN2 has not previously been associated with disease in humans. We assessed DNA sequence variants around CLDN2 and RNA and protein expression for claudin-2 in control tissue classified by histology and genotype ( Supplementary  Fig. 10 and Supplementary Table 6 ). Evaluating 1000 Genomes Project data, we did not identify exonic variation that could explain the association signal. Using similar methods to those described for the analysis of PRSS1 expression, we determined that CLDN2 expression levels in control tissues did not correlate with genotype at the CLDN2 risk locus (P = 0.32). Protein blot analysis of protein extracted from the tissue npg l e t t e r s with antibody to claudin-2 detected only one protein band of the appropriate size, the expression of which correlated with tissue inflammation, as determined by systematic grading of histology in adjacent tissue ( Fig. 2a and Supplementary Fig. 10 ). Immunohistochemical staining with antibody to claudin-2 was verified in normal tissue (Fig. 2b) , with kidney, duodenum and bile ducts serving as additional positive controls (data not shown). We assessed protein localization in 12 GWAS cases who underwent pancreatic surgery (6 with the high-risk genotype at CLDN2 and 6 without this genotype). Claudin-2 staining of cytoplasmic granules was markedly higher in both duct and acinar cells in chronic pancreatitis cases as compared with controls. (Fig. 2c-e ). Only chronic pancreatitis cases with the high-risk CLDN2 genotype showed moderate-to-strong claudin-2 staining along the basolateral membrane of acinar cells (Fig. 2d,e and Supplementary  Table 6 ). Claudin-2 was also expressed in macrophages, which could contribute to the pathological inflammatory process 25 (Fig. 2c,f) .
Most studies report excessive alcohol consumption as the major risk factor for adult-onset chronic pancreatitis [26] [27] [28] [29] . However, only 3% of individuals who are alcoholics develop chronic pancreatitis 30 , suggesting a pancreas-specific risk factor. We compared genotypes on the basis of whether pancreatitis was alcohol related (yes/no) 5, 31 . Setting control genotype counts as the baseline category against which case genotypes were compared, the jointly estimated odds ratios for cases with positive alcohol-related pancreatitis were greater for both rs10273639 (PRSS1-PRSS2 locus) and rs12688220 (CLDN2 locus) than those estimated for cases with pancreatitis not related to alcohol consumption ( Table 3) . Thus, the effects of both loci seemed to be amplified by alcohol consumption. In a case-only analysis, both loci seemed to interact with alcohol-related pancreatitis ( Table 3) , with the association for the CLDN2 locus being more prominent (P = 4 × 10 −7 ).
We conclude that a common allele in the PRSS1-PRSS2 locus is associated with lower PRSS1 gene expression and that this effect is independent of the previously reported rare gain-of-function PRSS1 variants that increase susceptibility to both recurrent acute pancreatitis and chronic pancreatitis 8 . For this reason and because risk variants at the PRSS1-PRSS2 locus exert a similar effect in subjects with recurrent acute pancreatitis and those with chronic pancreatitis, it is reasonable to conjecture that variation at rs10273639 or variation at sites in linkage disequilibrium with it directly affects risk for chronic pancreatitis and recurrent acute pancreatitis through its impact on trypsinogen expression. Variation at the CLDN2 locus, however, is much more strongly associated with chronic pancreatitis than recurrent acute pancreatitis, suggesting that it probably acts as a disease modifier to accelerate the transition from recurrent acute pancreatitis to chronic pancreatitis. The significant association of the CLDN2 Chr., chromosome; OR, odds ratio; se(OR), standard error of the odds ratio. a A1 is the allele counted for purposes of computing the odds ratio and associated statistics. The model used here includes covariates to control for the two leading eigenvectors for ancestry, as was done in the PLINK analyses, but differs in its treatment of the minor allele count for the CLDN2 locus, which resides on the X chromosome (Online Methods). Alleles given are refSNP alleles according to dbSNP. All SNPs passing quality control and showing association at P < 5 × 10 −7 in stage 1 or 2 or the joint analysis are listed in supplementary table 2.
npg l e t t e r s locus with alcohol-related disease suggests that the high-risk allele in the CLDN2 locus may modify risk through a non-trypsin-dependent process. Thus, we have characterized two common genetic risk modifiers for sporadic and alcohol-related chronic pancreatitis.
URLs. The Developmental Studies Hybridoma Bank at the University of Iowa, http://dshb.biology.uiowa.edu/Antibody-list.
MeThods
Methods and any associated references are available in the online version of the paper.
Note : Supplementary information is available in the online version of the paper. Using data from cases only in a joint analysis of both SNPs, rs12688220 predicts alcohol-related pancreatitis on the basis of genotype (χ 2 = 29.57; degrees of freedom (DF) = 2; P = 4 × 10 −7 ) or count of risk alleles (χ 2 = 13.17; DF = 1; P = 3 × 10 −4 ). rs10273639 (PRSS1-PRSS2 locus) is a significant predictor (count of risk alleles: χ 2 = 5.68; DF = 1; P = 0.017; genotypes: χ 2 = 6.05; DF = 2; P = 0.049), even after accounting for the effects of rs12688220.
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